Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol

scientific article published on 2 November 2006

Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMJCARD.2006.07.053
P698PubMed publication ID17196452

P50authorJames B. MeigsQ64426927
Mason W. FreemanQ91364980
P2093author name stringRichard W Grant
Doreen DeFaria Yeh
P2860cites workHigh density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transportQ34123188
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectlipoproteinQ28350
coronary artery diseaseQ844935
HDL cholesterolQ67322514
artery diseaseQ18965518
P304page(s)1-4
P577publication date2006-11-02
P1433published inAmerican Journal of CardiologyQ2208417
P1476titleRisk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol
P478volume99

Reverse relations

cites work (P2860)
Q90310484Association between APOE polymorphisms and lipid profile in Mexican Amerindian population
Q33898681Diagnosis and management of mineral metabolism in CKD.
Q33518929Documentation of body mass index and control of associated risk factors in a large primary care network
Q39022051Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease
Q33505849Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records
Q34078271KCNQ1 gene polymorphisms are associated with lipid parameters in a Chinese Han population
Q34286105Patient-physician connectedness and quality of primary care
Q30235227Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure
Q90523967The Metabolic Changes of Artesunate and Ursolic Acid on Syrian Golden Hamsters Fed with the High-Fat Diet
Q33534537The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Search more.